Browse Transdermal medication topic

Subtopics (32)

• Achievements and awards
• Cases
• Complications and side effects
• Conferences, meetings and seminars
• Dosage and administration
• Environmental aspects
• Equipment and supplies
• Evaluation
• Genetic aspects
• Growth
• Health aspects
• Innovations
• Intellectual property
• Labeling
• Licensing agreements
• Licensing, certification and accreditation
• Market research
• Methods
• Physiological aspects
• Planning
• Product defects and recalls
• Product development
• Product information
• Quality management
• Reports
• Research
• Safety and security measures
• Statistics
• Surveys
• Technology application
• Testing
• Usage

Articles

Title	Author	Type	Date	Words
Antares Pharma Enters into License and Asset Purchase Agreements with Ferring.			Nov 11, 2009	835
Zosano Pharma, Inc. Announces Publication of Positive Phase 2 Study of Its ZP-PTH Patch for Osteoporosis Therapy.		Clinical report	Nov 9, 2009	982
FDA Approves Pennsaid[R] Topical Solution.			Nov 5, 2009	863
AllTranz Awarded $4 Million Research Grant by NIH and NIDA.			Nov 3, 2009	733
Zosano Pharma, Inc. to Provide Pipeline Updates at the 2009 AAPS Annual Meeting.			Nov 2, 2009	386
Completion of Phase I Clinical Trial of Sancuso[R] in Japanese Volunteers.			Oct 30, 2009	385
3M Drug Delivery Systems Expands with New Singapore Lab.			Oct 7, 2009	486
BioChemics, Inc. Announces Collaboration Agreement with Unilever.			Oct 5, 2009	235
BioChemics, Inc. to Present at Second Annual Boston Biotech R&D Conference.		Conference news	Oct 1, 2009	470
Zelrix, a Novel Transdermal Patch for Migraine, Found to Provide Rapid, Consistent, and Sustained Relief for Migraine Sufferers in Phase III Trial.			Sep 10, 2009	1027
25th Anniversary LTS LOHMANN Therapie-Systeme AG.			Sep 1, 2009	382
TransPharma Announces Successful Completion of Phase 2 Trial of ViaDerm-hPTH (1-34) in Postmenopausal Women with Osteoporosis.			Sep 1, 2009	605
United States : ProStrakan Receives US FDA Approval for Sancuso.			Aug 24, 2009	464
BioChemics, Inc. Announces Collaboration Agreement with Pacific Pharmaceutical Co., Ltd.			Aug 5, 2009	472
Zosano Pharma, Inc. Secures $30 Million in New Round of Financing.			Jul 7, 2009	634
Don't get burned at your next MRI.	Watts, Theresa		Jul 1, 2009	237
Antares Pharma Announces Partners Update of LibiGel[R] Safety Study.		Clinical report	Jun 17, 2009	1204
BioChemics, Inc. Announces Expanded Scope of Collaboration with a Leading Light Based Technology Company.			Jun 3, 2009	426
Sancuso[R] Clinical Trial Application Filed in China.			Jun 1, 2009	340
Delivering vaccine through the skin may prevent ear infections in future.			May 22, 2009	380
Transdermal Pain Drug Market Underdeveloped Beyond North America.			May 13, 2009	366
Flu vaccine given in microneedle skin patches offers new hope.			Apr 28, 2009	322
Altea Therapeutics Announces Development and Commercialization Agreement with Amylin and Lilly for an Investigational Transdermal Exenatide.			Apr 1, 2009	858
Noven Provides Update on Daytrana[R] Methylphenidate Transdermal System.			Mar 20, 2009	1269
Noven Confirms Shire's Withdrawal of European Marketing Application for Daytrana[R].			Mar 16, 2009	420
Teikoku Pharma USA and Eisai Co., Ltd Announce Licensing Agreement for a New 7-Day Transdermal Formulation of donepezil.			Mar 10, 2009	306
Clinical Development of Solasia's First Drug Initiated in Japan - Clinical Trials Also Planned for China.			Mar 9, 2009	477
United States: Transdel Pharmaceuticals, Inc. Featured on National Broadcast Television.			Feb 26, 2009	145
Research and Markets: Analyse the Market for Transdermal Drug Delivery According To Technologies and Therapeutic Areas from 2008 To 2018.			Feb 6, 2009	316
Another way to take magnesium.	Klotter, Jule		Feb 1, 2009	548
Zosano Pharma, Inc. to Present at the 13th Annual Drug Delivery Partnerships Meeting.			Jan 19, 2009	489
Testosterone for Low Libido.			Jan 1, 2009	1242
TransPharma Receives European CE Mark Approval for its Transdermal Drug Delivery Device.			Dec 15, 2008	408
Zosano Pharma, Inc. Completes Positive End-of-Phase 2 Meeting With FDA Regarding ZP-PTH Patch for Osteoporosis.			Dec 9, 2008	606
Antares Pharma and Population Council Announce Initiation of Phase II Clinical Trial for a Novel Contraceptive ATD Gel.			Nov 24, 2008	1526
J&J recalls pain device in Europe, US launch affected.			Nov 1, 2008	435
Zosano Pharma, Inc. to Present at BIO Investor Forum.			Oct 23, 2008	316
3M and VaxInnate Collaborate to Develop Flu Vaccine Patch.			Oct 20, 2008	548
Teva Announces FDA Approval and Commercial Launch of Fentanyl Transdermal System.			Oct 20, 2008	725
BioChemics, Inc. Announces Collaboration Agreement with Leading Light Based Technology Company.			Sep 30, 2008	406
Vyteris Announces Growth Initiative Through Expanded Business Development Team.			Sep 23, 2008	880
Xel Pharmaceuticals Announces Successful Completion of Prototype Once-A-Week Huperzine A Transdermal Patch for Alzheimer's Disease.			Sep 10, 2008	531
Novel methothrexate-based topical therapies for effective treatment of psoriasis.	Dubey, Vaibhav; Mishra, Dinesh; Nahar, Manoj; Jain, Narendra Kumar		Sep 1, 2008	3923
Noven Provides Update on Daytrana(R) Methylphenidate Transdermal System.			Aug 25, 2008	1085
United States: Noven signs license and supply agreements with Procter & Gamble Pharmaceuticals.			Aug 23, 2008	208
Noven Signs License and Supply Agreements with Procter & Gamble Pharmaceuticals for Patches to Treat HSDD.			Aug 20, 2008	820
Vyteris Annouces Key Scientific Advisors.			Aug 19, 2008	1064
Altea Therapeutics Forms Premier Scientific Advisory Board.			Aug 8, 2008	942
Vyteris Announces Launch of Initiative to Pursue Joint Development Agreements in Pain Management.			Aug 5, 2008	604
Noven Announces Triggering of $25 Million Daytrana(R) Sales Milestone.			Aug 4, 2008	686
Frost & Sullivan Honours TransPharma Medical for its Innovative ViaDerm Drug Delivery System.			Aug 2, 2008	668
World-First Breakthrough for Women's Sexual Satisfaction.			Jul 31, 2008	993
Vyteris Announces Successful Completion of Peptide Dose Ranging Study in Preparation for Phase II Human Clinical Trials.		Report	Jul 28, 2008	614
NuPathe Inc. Completes $30 Million Series B Financing.			Jul 24, 2008	707
Novel Drug Delivery Mechanisms Offer Significant Potential for the European Pharmaceutical Industry.		Industry overview	Jul 24, 2008	535
Vyteris, Inc. Receives $2.5 Million Loan from Ferring Pharmaceuticals, Inc.			Jul 21, 2008	649
Blue Spark Technologies Unveils Innovative Printed Battery Designs.			Jul 14, 2008	683
Altea Therapeutics and Hospira enter into Development and Commercialization Agreement for Transdermal Product.		Clinical report	Jul 2, 2008	642
Vyteris, Inc. Announces Completion of Reverse Stock Split and New Trading Symbol.			Jun 17, 2008	508
NuPathe Inc. CEO to Present at the Leerink Swann Emerging Technologies in Pain Medicine Conference, New York City, Monday, June 23, 2008, Sofitel New York.		Conference news	Jun 16, 2008	350
Vyteris Announces Plans to Pursue Strategy for Transdermal Drug Delivery Technology.			Jun 11, 2008	723
Noven Provides Update on Daytrana(TM) Methylphenidate Transdermal System.			Jun 9, 2008	1070
Dr. R. Rox Anderson Joins BioChemics Scientific Advisory Board to Advise on Development of Dermatological Products.			Jun 3, 2008	666
ProStrakan and JapanBridge Partner to Develop Sancuso(R) in Japan, China & Parts of South East Asia.			May 23, 2008	770
arGentis Licenses Third Treatment for Dry Eye Syndrome.			May 12, 2008	515
Transdermal Drug Delivery -- Technologies, Markets, and Companies.			May 7, 2008	311
Dr. Roy Altman Joins BioChemics Scientific Advisory Board to Advise on Clinical Development of Targeted Osteoarthritis Therapy.			May 7, 2008	775
Questionable delivery.	Teichmuller, Sarah	Letter to the editor	May 1, 2008	299
Blood clots and "The Patch".			May 1, 2008	1283
Lux Biosciences' Presentations at ARVO Highlight Both Topical and Polymer Delivery Technologies Targeting Chronic Inflammatory Ocular Diseases.			Apr 28, 2008	935
Antares Pharma's Partner to Initiate Phase III Trial for CNS Therapy in Q4 2008.			Apr 15, 2008	752
Company Profile for BioChemics, Inc.		Company overview	Apr 11, 2008	255
BioChemics & Beth Israel Deaconess Medical Center Announce Wound Healing Research Collaboration.			Apr 8, 2008	710
Antares Pharma Announces Issuance of Key Patent Covering ATD(TM) Technology.			Apr 7, 2008	688
VIVUS Completes Special Protocol Assessment for Phase 3 Efficacy Studies and Reaches Agreement with the FDA on the Safety Study for Luramist (Testosterone MDTS).			Apr 1, 2008	1514
Recall of transdermal fentanyl patch tests procedures at hospice agencies.			Apr 1, 2008	1280
Australia: Strategic focus on reducing expenditure and realising assets.			Mar 19, 2008	328
Topical betamethasone in the treatment of chronic plaque psoriasis: a review.	Prasutr, Thawornchaisit	Clinical report	Mar 1, 2008	4305
Antares Receives Positive Guidance for European Registration.			Feb 12, 2008	1239
Vyteris Announces Redirection of Business Towards the Advancement of Peptide Delivery.			Feb 1, 2008	689
FDA action prompts BDSI to develop safety plan for patch.	Pickett, Joseph	Report	Jan 29, 2008	480
Warning added to birth control patch label.		Report	Jan 29, 2008	312
Vyteris Announces First Successful Non-Invasive Delivery of Peptide Using Smart Patch Technology.		Medical condition overview	Jan 22, 2008	972
Noven Receives FDA Warning Letter Related to Mid-2007 Facility Inspection.			Jan 10, 2008	738
BioSante Pharmaceuticals Announces Initiation of LibiGel(R) (Transdermal Testosterone Gel) Phase III Safety Study.		Report	Jan 7, 2008	1277
Transdermal delivery: marketers rely on a variety of ways to deliver active materials to the skin.	Burke, LaToyah		Jan 1, 2008	1933
InSite Vision Initiates Pivotal Phase 3 Trials for AzaSite Plus(TM).			Dec 20, 2007	1149
Antares Pharma Receives Milestone Payment.			Dec 19, 2007	678
Frost & Sullivan Recognizes Transport Pharmaceuticals' Innovative Electrokinetic Drug Delivery Platform for Contributing to Clinical Outcomes.		Company overview	Dec 10, 2007	695
Zosano Pharma, Inc. Closes Enrollment in Phase 2 Trial.			Nov 28, 2007	562
Antares Pharma to Present at BMO Capital Markets Focus on Healthcare Conference.		Conference news	Nov 28, 2007	215
Antares Pharma to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference.		Conference news	Oct 29, 2007	217
Antares' Product Development Agreement Wins 2007 Innovative Bio-Partnering Award.			Oct 16, 2007	696
BioSante Pharmaceuticals To Present Validation Data Required for Development of LibiGel(R) (transdermal testosterone gel) in the Treatment of Female Sexual Dysfunction.			Oct 4, 2007	1166
First federal fentanyl patch trial begins in Florida.			Jun 18, 2007	337
EVRA and Venous Thrombosis.		Clinical report	Apr 1, 2006	856
Testosterone and Sexuality.			Jan 1, 2001	755
Testosterone and Sexuality.			Nov 1, 2000	729
Estradiol/Norethindrone Acetate Transdermal Systems (CombiPatch).			Feb 1, 1999	811
Laser monitor approved for home use by diabetics.			Jan 1, 1999	626